Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -- | -- | 158.72% | -61.54% | -- |
Total Receivables | -32.71% | -51.15% | -63.18% | -19.59% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1,745.45% | 485.71% | 3,788.89% | 175.00% | -- |
Total Current Assets | -26.58% | -49.72% | -36.15% | -21.20% | -- |
|
|||||
Total Current Assets | -26.58% | -49.72% | -36.15% | -21.20% | -- |
Net Property, Plant & Equipment | 170.47% | 222.90% | 130.07% | 65.58% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -12.82% | -32.07% | -28.76% | -14.43% | -- |
|
|||||
Total Accounts Payable | 959.86% | 642.33% | 1,081.98% | 559.00% | -- |
Total Accrued Expenses | 2,059.38% | 2,600.85% | 1,602.40% | 792.59% | -- |
Short-term Debt | 353.41% | 360.15% | 52.54% | 41.71% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 318.73% | 706.07% | 746.44% | 180.70% | -- |
Total Other Current Liabilities | 318.73% | 706.07% | 746.44% | 180.70% | -- |
Total Current Liabilities | 475.49% | 723.69% | 628.38% | 258.38% | -- |
|
|||||
Total Current Liabilities | 475.49% | 723.69% | 628.38% | 258.38% | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 353.41% | 360.15% | 52.54% | 41.71% | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 475.49% | 723.69% | 628.38% | 258.38% | -- |
|
|||||
Common Stock & APIC | 2,107.44% | 22,007.88% | -- | 2,332.37% | -- |
Retained Earnings | -2,378.42% | -16,711.59% | -4,694.29% | -3,103.03% | -- |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -6,430.77% | -1,480.60% | -567.82% | -613.99% | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -6,430.77% | -1,480.60% | -567.82% | -613.99% | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6,423.98% | -1,478.81% | -566.97% | -613.99% | -- |
|